[Side effects of methylperone in long-term therapy up to 8 years].
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy; D001794:Blood Pressure; D001799:Blood Sedimentation; D002090:Butyrophenones / Q000009:adverse effects* / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003704:Dementia / Q000097:blood / Q000188:drug therapy; D004562:Electrocardiography; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007958:Leukocyte Count; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000097:blood / Q000188:drug therapy; D010259:Paranoid Disorders / Q000097:blood / Q000188:drug therapy; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy; D013997:Time Factors; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D002090:Butyrophenones; D010880:Piperidines; D014149:Tranquilizing Agents; D003404:Creatinine; D000410:Alanine Transaminase
Nebenwirkungen von Methylperone bei Dauerbehandlung bis zu 8 Jahren